CLINICAL_TRIALS
trial_result
· 2024-08-15
Clinical Trial Update: First Step With Singulair® Therapy (0476-323) [Phase 4]
Summary
Phase 4 post-approval trial update for Singulair (montelukast) in asthma, indicating the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Asthma | Phase 4 | Status: COMPLETED